Aubagio and Cognitive disorder - a phase IV clinical study of FDA data
Cognitive disorder is found among people who take Aubagio, especially for people who are female, 50-59 old, have been taking the drug for 1 - 6 months.
The phase IV clinical study analyzes which people take Aubagio and have Cognitive disorder. It is created by eHealthMe based on reports of 43,868 people who have side effects when taking Aubagio from the FDA, and is updated regularly. You can use the study as a second opinion to make health care decisions.
Phase IV trials are used to detect adverse drug outcomes and monitor drug effectiveness in the real world. With medical big data and AI algorithms, eHealthMe is running millions of phase IV trials and makes the results available to the public. Our original studies have been referenced on 600+ medical publications including The Lancet, Mayo Clinic Proceedings, and Nature.
43,868 people reported to have side effects when taking Aubagio.
Among them, 633 people (1.44%) have Cognitive disorder.
What is Aubagio?
Aubagio has active ingredients of teriflunomide. It is often used in multiple sclerosis. eHealthMe is studying from 44,008 Aubagio users for its effectiveness, alternative drugs and more.
What is Cognitive disorder?
Cognitive disorder (mental health disorders affects learning, memory, perception, and problem solving) is found to be associated with 2,208 drugs and 1,659 conditions by eHealthMe.
Number of Aubagio and Cognitive disorder reports submitted per year:
Time on Aubagio when people have Cognitive disorder *:
Gender of people who have Cognitive disorder when taking Aubagio*:
Age of people who have Cognitive disorder when taking Aubagio *:
Common drugs people take besides Aubagio *:
Common side effects people have besides Cognitive disorder *:
Common conditions people have *:
* Approximation only. Some reports may have incomplete information.
Do you take Aubagio and have Cognitive disorder?Check whether Cognitive disorder is associated with a drug or a condition
How to use the study?
You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.
How severe was Cognitive disorder and when was it recovered:
Expand to all the drugs that have ingredients of teriflunomide:
Alternative drugs to, pros and cons of Aubagio:
- Aubagio (44,008 reports)
Common Aubagio side effects:
Browse all side effects of Aubagio:a b c d e f g h i j k l m n o p q r s t u v w x y z
Cognitive disorder treatments and more:
- Cognitive disorder (48,634 reports)
COVID vaccines that are related to Cognitive disorder:
- Cognitive disorder in Moderna COVID Vaccine
- Cognitive disorder in Pfizer BioNTech Covid Vaccine
- Cognitive disorder in Johnson and Johnson Covid Vaccine
Common drugs associated with Cognitive disorder:
All the drugs that are associated with Cognitive disorder:
- Cognitive disorder (2,208 drugs)
Common conditions associated with Cognitive disorder:
All the conditions that are associated with Cognitive disorder:
- Cognitive disorder (1,659 conditions)
How the study uses the data?
The study uses data from the FDA. It is based on teriflunomide (the active ingredients of Aubagio) and Aubagio (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.
Who is eHealthMe?
With medical big data and proven AI algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 600+ medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Lasix and Bipolar Disorder - now
- Norethidrone vs. Norgestimate; Ethinyl Estradiol - 18 seconds ago
- Hydramine and Renal Pain - 19 seconds ago
- Fluorescite and Arrhythmias - 26 seconds ago
- Dry Skin and drugs of ingredients of fludrocortisone acetate - 37 seconds ago
- Victrelis and Stress And Anxiety - 53 seconds ago
- Doxycycline Hyclate and Rosacea - 59 seconds ago
- Herpes Simplex and Angioedema - 59 seconds ago
- Trandolapril and Melaena - a minute ago
- Cytomel and Hypersensitivity - a minute ago